A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

Journal of Virology
Meagan BollesRalph Baric

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) is an important emerging virus that is highly pathogenic in aged populations and is maintained with great diversity in zoonotic reservoirs. While a variety of vaccine platforms have shown efficacy in young-animal models and against homologous viral strains, vaccine efficacy has not been thoroughly evaluated using highly pathogenic variants that replicate the acute end stage lung disease phenotypes seen during the human epidemic. Using an adjuvanted and an unadjuvanted double-inactivated SARS-CoV (DIV) vaccine, we demonstrate an eosinophilic immunopathology in aged mice comparable to that seen in mice immunized with the SARS nucleocapsid protein, and poor protection against a nonlethal heterologous challenge. In young and 1-year-old animals, we demonstrate that adjuvanted DIV vaccine provides protection against lethal disease in young animals following homologous and heterologous challenge, although enhanced immune pathology and eosinophilia are evident following heterologous challenge. In the absence of alum, DIV vaccine performed poorly in young animals challenged with lethal homologous or heterologous strains. In contrast, DIV vaccines (both adjuvanted and unadjuvanted)...Continue Reading

References

May 8, 2003·JAMA : the Journal of the American Medical Association·Christopher M BoothAllan S Detsky
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Boyd YountRalph S Baric
Jan 31, 2004·Science·UNKNOWN Chinese SARS Molecular Epidemiology Consortium
Feb 14, 2004·Science·Eliot Marshall, Martin Enserink
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Aug 18, 2004·International Immunology·Naomi TakasukaYasuko Tsunetsugu-Yokota
Nov 9, 2004·Biochemical and Biophysical Research Communications·Yuxian HeShibo Jiang
Feb 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Huai-Dong SongGuo-Ping Zhao
Aug 27, 2005·Journal of Medical Virology·Jian-San ZhangWei-Dong Yin
Sep 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Susanna K P LauKwok-Yung Yuen
Oct 1, 2005·Science·Wendong LiLin-Fa Wang
Oct 1, 2005·Science·Dennis Normile
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Joseph M ThompsonRobert E Johnston
Jul 25, 2006·Nature Medicine·Amin MoghaddamPeter J M Openshaw
Sep 14, 2006·PLoS Medicine·Lauren J StockmanPaul Garner
Oct 14, 2006·Advances in Experimental Medicine and Biology·Timothy SheahanRalph Baric
Jan 4, 2007·The Journal of Pathology·A L GruverG D Sempowski
Jan 16, 2007·PLoS Pathogens·Anjeanette RobertsKanta Subbarao
Apr 10, 2007·Virus Research·Luis EnjuanesRalph Baric
May 15, 2007·Virus Research·Anjeanette RobertsKanta Subbarao
Jul 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Zhongyu ZhuDimiter S Dimitrov
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fumihiko YasuiMichinori Kohara
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elaine M CastilowSteven M Varga
Nov 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michelle M BeckerMark R Denison

❮ Previous
Next ❯

Citations

Nov 10, 2015·Nature Medicine·Vineet D MenacheryRalph S Baric
Dec 3, 2015·EBioMedicine·Vineet D Menachery
May 23, 2014·Immunologic Research·Rudragouda ChannappanavarStanley Perlman
Mar 16, 2016·Proceedings of the National Academy of Sciences of the United States of America·Vineet D MenacheryRalph S Baric
Jul 21, 2015·Antiviral Research·Neeltje van Doremalen, Vincent J Munster
Jul 18, 2015·Current Opinion in Virology·Lisa M Gretebeck, Kanta Subbarao
Oct 4, 2014·Virus Research·Vineet D MenacheryRalph S Baric
May 11, 2012·Current Opinion in Virology·Allison L Totura, Ralph S Baric
Apr 12, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Stanley Perlman, Rahul Vijay
Oct 28, 2016·Reviews in Medical Virology·Naif Khalaf Alharbi
Jul 7, 2018·Journal of Virology·Vineet D MenacheryRalph S Baric
Aug 24, 2017·MBio·Vineet D MenacheryRalph S Baric
Mar 9, 2019·Expert Opinion on Drug Discovery·Allison L Totura, Sina Bavari
Nov 13, 2013·Nature Reviews. Microbiology·Rachel L GrahamRalph S Baric
Aug 29, 2017·Human Vaccines & Immunotherapeutics·Joel N Maslow
Dec 6, 2019·Journal of Virology·Vineet D MenacheryRalph S Baric
May 8, 2020·Emerging Microbes & Infections·Lunzhi YuanNingshao Xia
May 5, 2020·The Journal of Infectious Diseases·Kevin W GraepelKathryn E Edwards
May 21, 2020·Nature Communications·Trevor R F SmithKate E Broderick
May 10, 2020·Science·Barney S Graham
Apr 30, 2020·Nature Reviews. Immunology·Matthew Zirui TayLisa F P Ng
Apr 15, 2020·Journal of Medical Virology·Nevio Cimolai
May 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tulika SinghSallie R Permar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.